These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Disease modifying drugs in multiple sclerosis and pregnancy]. Tur C, Tintoré M, Aguilera C. Med Clin (Barc); 2012 Sep 22; 139(7):316-8. PubMed ID: 22743277 [No Abstract] [Full Text] [Related]
3. The pill times 2: what every woman with multiple sclerosis should know. Langer-Gould AM. Neurology; 2014 Feb 25; 82(8):654-5. PubMed ID: 24463629 [No Abstract] [Full Text] [Related]
4. Multiple sclerosis: Study reinforces need for contraception in women taking fingolimod. Jones B. Nat Rev Neurol; 2014 Mar 25; 10(3):125. PubMed ID: 24514867 [No Abstract] [Full Text] [Related]
5. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis. Castillo-Trivino T, Lopetegui I, Alarcón-Duque JA, López de Munain A, Olascoaga J. J Neurol Neurosurg Psychiatry; 2015 Aug 25; 86(8):931-2. PubMed ID: 25835036 [No Abstract] [Full Text] [Related]
12. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod]. Komoly S. Ideggyogy Sz; 2012 Nov 30; 65(11-12):421-2. PubMed ID: 23289178 [No Abstract] [Full Text] [Related]
13. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X. Ophthalmology; 2013 Jul 30; 120(7):1432-9. PubMed ID: 23531349 [Abstract] [Full Text] [Related]